The immune system has evolved to mediate protective responses against pathogens with the process of acute inflammation contributing to fight off infection. However, timely control of exacerbated inflammation is crucial to prevent immunopathology as is evident from the pathogenesis of both infectious and non-infectious diseases. In case of malaria too, severe pathogenesis has been attributed to an overexuberant proinflammatory cytokine response.^[@bib1]^ Notably, interleukin (IL)-10 has a non-redundant role in limiting the inflammatory response by way of inhibiting the production and release of a range of proinflammatory cytokines.^[@bib2]^ In addition to T-helper cells, monocytes, macrophages and dendritic cells being the major cell sources of IL-10, a number of other immune cells such as B cells, cytotoxic T cells, natural killer cells, mast cells, neutrophils and eosinophils are also capable of producing the cytokine in certain contexts.^[@bib3]^ However, it is suggested that cell source of IL-10 depends on the pathogen type, that is, cell-specific transcriptional regulatory machinery is triggered in response to specific pathogen.^[@bib4],\ [@bib5]^ Significantly, in our previous longitudinal study, we reported deficient IL-10 production with an exaggerated proinflammatory response in severe falciparum malaria.^[@bib6]^ This prompted us to investigate the transcriptional regulation of this indispensable anti-inflammatory cytokine.

In the present study, signalling proteins and transcription factors regulating the macrophage, Th1 and Th2 cell-specific transcription of IL-10 were taken into consideration.^[@bib2]^ Expression profile of the factors was analysed between severe and uncomplicated falciparum malaria patients from the period of active infection till resolution of parasitaemia. The signalling proteins in the panel included common signalling proteins MAPK1, MAPK3, macrophage-specific p38, T~H~1-specific STAT4 and T~H~2-specific STAT6. The transcription factors included common transcription factor c-MAF, macrophage-specific ATF, SP1, C/EBPβ, nuclear factor-κB (NF-κB), T~H~1-specific T-bet, SMAD4 and T~H~2-specific GATA3. Further, the molecules involved in IL-10 production downstream of toll-like receptor (TLR) signalling, which include TRAF3, IFN-α, IFN-β, IL-27 in addition to negative regulators CIITA and ETS-1 were also considered. We also included SOCS3, which is a direct mediator of IL-10 inhibition of proinflammatory cytokines. Results revealed a reduced expression of T-bet and GATA3 in severe malaria (SM) indicating that T-helper cells might be involved as major source of IL-10 during malaria infection and hence in prevention of immunopathology.

Results
=======

Patient characteristics
-----------------------

The demographic and clinical characteristics of the longitudinal cohort from which the samples for the present study were selected, have been described previously.^[@bib6]^

Differential clustering of regulatory factors and cytokines between SM and uncomplicated malaria
------------------------------------------------------------------------------------------------

Heat maps were generated for both day 0 and day 3 expression profile of the regulatory factors and cytokines in SM and uncomplicated malaria (UM; [Supplementary Figures 1 and 2](#sup1){ref-type="supplementary-material"}). Data at the individual level revealed that 8 out of the 10 SM patients exhibited an overexpressed interferon (IFN)-α response. Importantly, expression of T-helper cell transcription factors T-bet and GATA3 was downregulated in all the SM patients. Strangely, in two of the SM patients, either IFN-α (MC 40) or IFN-β (MC 41) showed enhanced expression, whereas the other genes did not show notable change in expression levels. The clinical profiles of these two patients are given in [Table 1](#tbl1){ref-type="table"}. It was interesting to note that expression of either T-bet or GATA3 or both increased on day 3 with parasite clearance in SM individuals.

k-means clustering analysis of SM group using UM as the calibrator generated three clusters based on the similar patterns of expression profile from day 0 to day 3 ([Figure 1](#fig1){ref-type="fig"}). Cluster 2 with IFN-α exhibited a rapid decrease to normal levels by day 3. In contrast, T-bet and GATA3 in cluster 3 showed a pattern of reduced expression on day 0 followed by an increase to normal levels on day 3. Clustering analysis was also performed using healthy control as the calibrator ([Figure 2](#fig2){ref-type="fig"}). TRAF3, NF-κB, IFN-α and IFN-β, which are grouped under cluster 1, exhibited high expression on day 0 followed by a steep decrease. Again, cluster 2 with T-bet, GATA3, CIITA and ETS-1 was characterised by increased expression on day 3 compared with day 0. In UM, all the three clusters exhibited decrease of expression by day 3 ([Figure 2](#fig2){ref-type="fig"}). Collectively, the results obtained hints at the possible involvement of T-cell suppression in downregulated IL-10 levels of SM group. Thus, it was important to perform further comparative analysis of NF-κB, TRAF3, IFN-α, IFN-β, CIITA, ETS-1, T-bet and GATA3 between SM and UM.

Increased expression of TRAF3, IFN-α and decreased expression of T-bet, GATA-3 in SM
------------------------------------------------------------------------------------

The expression of TRAF3 and IFN-α in SM on day 0 was elevated with fold change levels of 2.15 (*P*=0.0002) and 3.11 (*P*=0.0005), respectively, compared with UM ([Figure 3](#fig3){ref-type="fig"}). Temporal expression analysis showed steep decrease in levels of both TRAF3 (*P*=0.0002) and IFN-α (*P*=0.0002) with parasite clearance post treatment in SM. Of note, there was decreased expression of T-bet and GATA3 on day 0 (*P*=0.01 and *P*\<0.0001) during the stage of active infection in SM followed by an increase on day 3 (*P*=0.04 for both the genes). The longitudinal expression profile of NF-κB, IFN-β, CIITA and ETS-1 was found to be comparable between the two disease groups.

Correlation between proinflammatory cytokines, parasitaemia and transcriptional regulatory factors
--------------------------------------------------------------------------------------------------

The expression pattern of IL-1β, TNF-α and IL-10 between SM and UM obtained by the SYBR Green method ([Supplementary Figure 3](#sup1){ref-type="supplementary-material"}) was similar to that obtained by TaqMan assays performed previously.^[@bib6]^ In both SM and UM, IL-10 levels positively correlated with GATA3 while there was also a weak positive correlation with T-bet in UM ([Figures 4a and f](#fig4){ref-type="fig"}). An inverse correlation was found between IL-10 and IFN-α as well as between IFN-α and GATA3 in SM ([Figures 4a and b](#fig4){ref-type="fig"}). Further, a moderate positive correlation was also observed between TRAF3 and IFN-α in SM. Significantly, NF-κB showed a weak positive association with proinflammatory cytokine TNF-α in SM suggesting the role of macrophages as inflammatory cells. Again, an exaggerated type I IFN response via TRAF3 induction could be triggered by parasite factors as suggested by the correlation pattern in [Figure 4d](#fig4){ref-type="fig"}. Interestingly, GATA3 expression seemed to decrease with increasing parasitaemia further supporting the role of decreased Th2 response in active infection ([Figure 4e](#fig4){ref-type="fig"}). However, T-bet did not exhibit any significant correlation with parasite density.

Altered expression of SOCS3 in SM
---------------------------------

Comparative analysis revealed reduced expression levels of SOCS3 ([Figure 5](#fig5){ref-type="fig"}) in SM on day 0 (*P*=0.0007) compared with UM followed by an increase on day 3 (*P*=0.02). As expected, the temporal expression pattern was similar to that of IL-10 determined in our previous study.^[@bib6]^ Notably, SOCS3 expression is reported to be directly regulated by IL-10.

Discussion
==========

IL-10 has a non-redundant role in maintaining the delicate balance between inflammation and immunoregulation during an immune response against pathogens.^[@bib2]^ The finding of association of decreased IL-10 with severe malaria in our previous study prompted us to investigate the macrophage, Th1 and Th2 cell-specific transcriptional regulation of this cytokine between SM and UM. Initial clustering analysis revealed differential clustering of the regulatory factors between SM and UM on the basis of change in expression profile with resolution of parasitaemia.

The most interesting observation was a marked downregulation in SM of Th1 and Th2 transcription factors, T-bet and GATA3, respectively. Importantly, results also showed a modest increase in the levels of the two factors with resolution of parasitaemia. At this point, it is interesting to ask if there could be a role for parasite factors in depressed expression of T-bet and GATA3. We analysed in context of parasitaemia and observed a negative correlation with GATA3. Considering that GATA3 is a critical transcription factor for IL-10 by Th2 cells, it may be speculated that this pathway could be involved in the observed suppressed levels of IL-10.^[@bib7]^ Another significant observation in SM was that proinflammatory cytokine IFN-α showed a moderate positive association with parasitaemia while correlating negatively with GATA3 and IL-10. A recent finding of special interest in this context is the ability of IFN-α to selectively repress GATA3 expression in fully committed Th2 cells by histone modifications.^[@bib8]^ Another recent study has shown the *Pf* genome to contain over 6000 AT-rich immunostimulatory motifs, which potently induce type I IFN transcription via an unidentified receptor that signals through STING-mediated pathway.^[@bib9]^ This view of the possible involvement of plasmodial DNA-induced type I IFN in malaria pathophysiology prompted us to hypothesize whether differential load of AT-rich DNA between SM and UM determines the extent of GATA3 suppression via IFN-α induction. Notably, high induction of TRAF3 observed in SM supports hyperactivation of IFN-α pathway.

Although T-bet was not correlated with parasitaemia like GATA3, a similar role of increased IFN-α in manipulating Th1 response towards downregulated IL-10 levels may be suggested. This is based on the reported involvement of type I IFNs in dampening the development of Th1 responses during malaria infection.^[@bib10]^ It is important to mention that IL-10 produced by IL-10+/IFN-γ+ co-producing Th1 cells has been demonstrated to regulate severe malaria pathogenesis in both human and experimental malaria.^[@bib11],\ [@bib12]^ Also, the switch from effector cytokine-producing IFN-γ+IL-10− Th1 cells to regulatory cytokine-producing IFN-γ-IL-10+ Th1 cells is dependent on a high environmental IL-2 production as well as T-bet.^[@bib13]^ Our data suggest that this switch is not operational in SM because there is not only low T-bet but also low IL-2 as reported in our previous study.^[@bib6]^ Further, T-regulatory (T-reg) cell activity is expected to be downregulated because dynamic expression of T-bet and of GATA3 is known to be associated with activated T-reg cells.^[@bib14]^ Consistent with this, expression of CTLA4 and Foxp3 (determined previously), the markers of T-reg cell function, was downregulated in SM.^[@bib6]^

Alternatively, macrophages could also be the source of IL-10 production downstream of MyD88 and TRIF signalling. Data revealed increased levels of p38 and NF-κB in some patients as well as of IFN-α and IL-27 in some others. In fact, upregulated expression of macrophage induction factors as well as modest levels of IL-10 was observed in one of the patients (MC3) indicating these cells to be involved in some amount of IL-10 production. Exceptions to this were two patients (MC 40 and MC 41) who had no detectable levels of both macrophage and T-helper cell regulatory factors. Instead, they demonstrated an exaggerated inflammatory response both in terms of type I IFNs and other inflammatory cytokines TNF-α and IL-1β as well as very low levels of IL-10. Notably, MC 40 and 41 samples had complications of acute renal failure coupled with low Glasgow coma score and severe anaemia, respectively, emphasizing the role of inflammation in severe malaria pathogenesis.

It is evident that IL-10 mediates anti-inflammatory response via SOCS3 and its production, in turn, is induced by IL-10.^[@bib15],\ [@bib16],\ [@bib17]^ Our data revealed a similar temporal expression profile of SOCS3 as that of IL-10 with depressed levels on day 0 followed by a steady increase on day 3. Hence, it follows that deficient production of SOCS3 resulted in inefficient regulation of over-exaggerated inflammation in severe malaria.

Pathogens during coevolution with their hosts have developed many immune evasion strategies in order to achieve persistence. Critical factors like NF-κB and MAPKs have also been targeted by pathogens for immune subversion.^[@bib18]^ Significantly, many viruses have been reported to manipulate cytokine response either by initiating a cytokine storm or by expressing IL-10 homologues.^[@bib19],\ [@bib20]^ Our data suggest two-pronged immune evasion strategy by falciparum pathogen. On one hand, the pathogen mediates activation of proinflammatory pathways involving IFN-α and NF-κB. On the other hand, a depressed IL-10 response together with suppression of IL-2, T-bet and GATA3 tends to suggest compromise of regulatory functions of T cells in falciparum malaria. Studies using purified cell populations will elucidate the role of different cell types in differential regulation of IL-10 in severe malaria. This propensity for a strong inflammatory response by upregulating proinflammatory with concomitant downregulation of anti-inflammatory response is likely to facilitate sequestration as exposure to proinflammatory cytokines is known to enhance endothelial activation.^[@bib10]^

In conclusion, our data suggest differential transcriptional regulation of IL-10 expression between SM and UM. Although Th1 and Th2 arm appeared to be operating optimally in UM, a suppressed IL-10 response in SM seemed to be mediated by manipulating T-bet and GATA3 levels. Additional studies with respect to parasite factors as well as the mechanisms involved in manipulation of T-bet and GATA3 expression with validation at the protein levels could be exploited to target exaggerated inflammation.

Materials and Methods
=====================

Study site, study design and subjects
-------------------------------------

The detailed description of the study site and the study population used in this study have been previously described.^[@bib6],\ [@bib21]^ Briefly, malaria patients stratified into SM and UM based on the World Health Organisation guidelines were followed up in a longitudinal study by multiple sampling at the stages of active infection before treatment (day 0), parasite clearance (day 3) and resolution of clinical symptoms (day 7). After obtaining written informed consent from the participants, venous blood was collected in RNAlater (Ambion, Austin, TX, USA) from the patients for all the 3 days. Only one sample for healthy control was collected. In addition, clinical data and parasitaemia were recorded. In the present study, 10 samples each of healthy control and of SM and UM groups with follow-up till day 3 were included. The study was approved by the Tezpur University Ethical Committee (DoRD/TUEC/10-14/453 dated 23/09/10).

Analysis of gene expression by real-time quantitative reverse transcription-PCR
-------------------------------------------------------------------------------

cDNA was generated from samples as previously described.^[@bib6]^ Expression analysis was performed using SYBR Green chemistry on a StepOnePlus Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). In addition to the regulatory factors, expressions were also checked for IL-10, TNF-α and IL-1β. Primers for some of the genes were designed using Primer Express software (Applied Biosystems) ([Table 2](#tbl2){ref-type="table"}) while for the other genes commercially available RT^2^ qPCR Primer Assays (Qiagen, Hilder, Germany) were used. IDT Oligoanalyzer tool (Integrated DNA Technologies, Coralville, IA, USA) was used to screen designed primers for secondary structure formation. Real-time PCR was carried out in 10 μl reaction volume consisting of 1 × SYBR Green PCR master mix, 0.4 μ[m]{.smallcaps} of each primer, 100 ng cDNA and water to adjust the volume using standard conditions. Gene expression analysis using TaqMan-based assay (Applied Biosystems) was performed only for *CTLA4* gene. Expression levels were normalised using GAPDH as the endogenous control while controls were used as the calibrator. The relative fold changes were calculated based on the 2^−ΔΔCT^ method. Melt curve analysis was performed to confirm the presence of specific amplification products.

Statistical analysis
--------------------

k-means clustering was performed to group the genes according to homogenous pattern of longitudinal gene expression. Clustering analysis for SM group was performed using healthy controls and UM as calibrator separately. The genes that clustered differently between SM and UM were further individually analysed for comparison of expression between the groups and within the same group using the unpaired and paired Student\'s *t*-test, respectively. Heat map analysis was also performed to check whether clusters of similar genes correspond to clusters of similar samples. Correlations between parasitaemia, cytokines and regulatory factors were evaluated by Pearson\'s correlation coefficient test. XLSTAT 2015 version (Addinsoft, New York, NY, USA) and GraphPad Prism version 5.0 (La Jolla, CA, USA) were used to carry out the statistical analyses.
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![k-means clustering analysis to group genes based on similar temporal expression profile from day 0 (stage of active infection before treatment) till day 3 (stage of parasite clearance post artesunate treatment) in (**a**) SM. The relative fold change was calculated with 2^−ΔΔCt^ formula using UM as the calibrator. 1, 2 and 3 denote the three clusters generated. The components of each of the clusters in SM are given in **b**.](cti201530f1){#fig1}

![k-means clustering analysis in (**a**) SM and (**b**) UM. The relative fold change was calculated with 2^−ΔΔCt^ formula using healthy control as the calibrator. 1, 2 and 3 denote the three clusters generated in the two disease groups. The components of each of the clusters in SM and UM are given in **c**.](cti201530f2){#fig2}

![mRNA expression profile of regulatory factors and cytokines, which were found to cluster differently in SM by k-means clustering analysis. Statistical comparison of day 0 expression levels between SM and UM was performed by unpaired *t*-test while expression levels between day 0 and day 3 within the disease groups was done by Student\'s paired *t*-test. Data are represented as ±s.e.m. \**P*\<0.05 and \*\**P*\<0.0001.](cti201530f3){#fig3}

![Correlation between cytokines, regulatory factors and parasitaemia in (**a**--**e**) SM and (**f**) UM. ((**a**) *r*=−0.730, 0.732, *P*=0.01, 0.01; (**b**) *r*=−0.859, 0.705, *P*=0.001, 0.02; (**c**) *r*=0.407, *P*=0.24; (**d**) r=0.427, 0.532, *P*=0.21, 0.11; (**e**) *r*=0.124, −0.665, *P*=0.73, 0.03; (**f**) *r*=0.459, 0.759, *P*=0.18, 0.01).](cti201530f4){#fig4}

![mRNA expression profile of SOCS3. \**P*\<0.05. Data are represented as ±s.e.m.](cti201530f5){#fig5}

###### Clinical data and relative mRNA expression of IL-10, IL-1β and TNF-α of two SM samples that showed different expression profile of the IL-10 transcriptional regulatory factors than the other patients

  *Clinical data and cytokine expression*    *MC 40*    *MC 41*
  ----------------------------------------- ---------- ----------
  Nausea                                       Yes        Yes
  Vomiting                                     Yes        Yes
  Jaundice                                     Yes         No
  Temperature (Fahrenheit)                     101         99
  Hb (g dl^−1^)                                 7         7.4
  Red colour of urine                          Yes         No
  Pulse per min                                 90         90
  Respiration per min                           18         16
  BP (mm Hg)                                  120/70     110/70
  Glasgow coma scale                            8          15
  Blood urea (mg dl^−1^)                        60         36
  Serum creatinine (mg dl^−1^)                 2.3        1.1
  Serum sodium (mmol l^−1^)                    135       130.1
  Serum potassium (mmol l^−1^)                 3.2        3.22
  Fold change of IL-10                       0.000179   1.002209
  Fold change of IL-1β                       0.000163   1.740216
  Fold change of TNF-α                       2.234853   3.224446

Abbreviations: BP, blood pressure; Hb, haemoglobin; IL, interleukin; SM, severe malaria; TNF, tumour necrosis factor.

The relative expression of the three cytokines was determined previously by TaqMan assay.^[@bib6]^ Expression analysis have also been performed using SYBR Green assay in the present study ([Supplementary figure 3](#sup1){ref-type="supplementary-material"}).

###### Sequences of designed primers for SYBR Green gene expression analysis

  *Gene name*   *Primers (forward and reverse)*
  ------------- ---------------------------------
  *IFN-α*       TCGCCCTTTGCTTTACTGATG
                CAGAGAGCAGCTTGACTTGCA
  *IFN-β*       TGCCTCAAGGACAGGATGAAC
                GGAACTGCTGCAGCTGCTTA
  *IL-27*       CCCTGATCGGTGGCTTCTTA
                GATGCCAAGACTCCAGTCCTAAA
  *SP1*         TGCCGCTCCCAACTTACAG
                TGTGGGATTACTTGATACTGAATATTAGG
  *C/EBPβ*      GGGTCTGAGACTCCCTTTCCTT
                CTCATTGGTCCCCCAGGAT
  *T-bet*       GATGCGCCAGGAAGTTTCA
                GTTGGACGCCCCCTTGTT
  *CIITA*       GATGCGCTGAGTGAGAACAAGA
                TTGAGGGTTTCCAAGGACTTCA
  *ETS-1*       AGGCAAGGACCTAGCAACACTTA
                GCTGGTGATAATTGGACTGGAAAC
  *IL-10*       GTGATGCCCCAAGCTGAGA
                CCCCCAGGGAGTTCACATG
  *IL-1β*       TCAGCCAATCTTCATTGCTCAA
                TGGCGAGCTCAGGTACTTCTG
  *TNF-α*       CCTGCCCCAATCCCTTTATT
                GCCCCCAATTCTCTTTTTGAG
